1. Home
  2. KTTA vs SPPL Comparison

KTTA vs SPPL Comparison

Compare KTTA & SPPL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Pasithea Therapeutics Corp.

KTTA

Pasithea Therapeutics Corp.

N/A

Current Price

$0.85

Market Cap

16.2M

Sector

Health Care

ML Signal

N/A

SPPL

SIMPPLE LTD.

N/A

Current Price

$2.01

Market Cap

18.2M

Sector

N/A

ML Signal

N/A

Company Overview

Basic Information
Metric
KTTA
SPPL
Founded
2020
2016
Country
United States
Singapore
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
16.2M
18.2M
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
KTTA
SPPL
Price
$0.85
$2.01
Analyst Decision
Strong Buy
Analyst Count
1
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
139.0K
7.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.28
$0.35
52 Week High
$2.34
$7.00

Technical Indicators

Market Signals
Indicator
KTTA
SPPL
Relative Strength Index (RSI) 51.11 29.79
Support Level $0.78 N/A
Resistance Level $0.88 $3.58
Average True Range (ATR) 0.07 0.35
MACD 0.01 -0.05
Stochastic Oscillator 62.10 1.29

Price Performance

Historical Comparison
KTTA
SPPL

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies and certain cancers. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia. Companies pipelines includes PAS-004 (Macrocyclic Small Module[MEK1/2]), PAS-003 (Monoclonal antibody),PAS-001 (Small Module).

About SPPL SIMPPLE LTD.

Simpple Ltd delivers an ecosystem solution that combines Internet-of-Things devices, robotic solutions, and an integrated software system operating in unison to position buildings to be future-ready. The company operates through two primary segments: the sale, warranty, and maintenance of autonomous robotic cleaning equipment (Robots), and the sale of facilities management software. The majority of its revenue is generated from the Robots segment.

Share on Social Networks: